Numerous clinical trials have studied the role of bone antiresorptive therapy for prevention of bone density loss and fractures.
已经有很多临床试验研究了骨的抗再吸收治疗在预防骨密度丢失和骨折中的作用。
2
Biochemical bone markers are useful for monitoring the efficacy of antiresorptive or anabolic therapy and may aid in identifying patients who have a high risk of fracture.